News & Events :: Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN

Recent NewsView All News

Mar 25, 2025 8:00am EDT

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital

Mar 18, 2025 8:00am EDT

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

Upcoming Events View All Events

April 25, 2025 12:00 pm EDT

2025 Annual Meeting of Stockholders

View All Events

Latest Presentation View All Presentations

Corporate Presentation

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings